These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1710739

  • 1. Pathophysiology of hyperlipidemia in diabetes mellitus.
    Abbate SL, Brunzell JD.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S1-7. PubMed ID: 1710739
    [Abstract] [Full Text] [Related]

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 3. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G, Giacco R, Patti L, Di Marino L, De Natale C, Costabile G, Marra M, Santangelo C, Masella R, Rivellese AA.
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [Abstract] [Full Text] [Related]

  • 4. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 6. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL.
    J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619
    [Abstract] [Full Text] [Related]

  • 7. Hyperlipidemia: forestalling complications in older diabetics.
    Chait A.
    Geriatrics; 1985 Apr; 40(4):71-3, 76-8. PubMed ID: 3884443
    [Abstract] [Full Text] [Related]

  • 8. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993 Apr; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 10. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS, Aslam M, Naveed AK, Razi MS.
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [Abstract] [Full Text] [Related]

  • 11. [On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)].
    Keimatsu M.
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):557-69. PubMed ID: 7319464
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
    Vergès BL.
    Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
    [Abstract] [Full Text] [Related]

  • 13. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 14. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
    Waysbort J, Regitz G, Brunner D.
    Clin Ther; 1988 Aug 15; 10(4):392-400. PubMed ID: 3152618
    [Abstract] [Full Text] [Related]

  • 15. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R, Borggreve SE, Dullaart RP.
    Clin Lab; 2003 Aug 15; 49(11-12):601-13. PubMed ID: 14651331
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec 15; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 17. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S.
    Ann Med Interne (Paris); 2001 Apr 15; 152(3):162-8. PubMed ID: 11431575
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 15; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 19. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB, Johnston P, Varasteh BB, Chen YD, Reaven GM.
    Diabete Metab; 1991 Jan 15; 17(5):483-9. PubMed ID: 1752350
    [Abstract] [Full Text] [Related]

  • 20. Dyslipoproteinaemia in manifest diabetes.
    Manzato E, Crepaldi G.
    J Intern Med Suppl; 1994 Jan 15; 736():27-31. PubMed ID: 7986305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.